Vera Therapeutics Inc (VERA)

Apr 19, 2025

When (VERA) Moves Investors should Listen - news.stocktradersdaily.com

Apr 19, 2025

Apr 18, 2025

Alliancebernstein L.P. Boosts Holdings in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Apr 18, 2025

Apr 18, 2025

Vera Therapeutics (VERA) Stock Sees After-Market Boost - Stocks Telegraph

Apr 18, 2025

Apr 15, 2025

Wellington Management Group LLP Trims Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Apr 15, 2025

Apr 15, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by JPMorgan Chase & Co. - Defense World

Apr 15, 2025

Apr 11, 2025

Polycythemia Vera Market to Show Remarkable Growth Trends from - openPR.com

Apr 11, 2025

Apr 11, 2025

Polycythemia Vera Therapeutics Market Set to Witness - openPR.com

Apr 11, 2025

Apr 09, 2025

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Apr 09, 2025

Apr 09, 2025

Kidney Disease-Focused Vera Therapeutics Concludes Enrollment In Pivotal Study, Targets 2026 Commercial Launch - Yahoo Finance

Apr 09, 2025

Apr 09, 2025

Vanguard Group Inc. Acquires 369,387 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Apr 09, 2025

Apr 06, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Purchased by Corebridge Financial Inc. - Defense World

Apr 06, 2025

Apr 06, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Consensus Rating of “Buy” from Analysts - Defense World

Apr 06, 2025

Apr 05, 2025

KLP Kapitalforvaltning AS Makes New Investment in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Apr 05, 2025

Apr 03, 2025

Vera Therapeutics completes enrollment for IgAN drug trial By Investing.com - Investing.com South Africa

Apr 03, 2025

Apr 03, 2025

Vera Therapeutics stock hits 52-week low at $21.44 By Investing.com - Investing.com South Africa

Apr 03, 2025

Apr 03, 2025

Vera Therapeutics stock hits 52-week low at $21.44 - Investing.com India

Apr 03, 2025

Apr 03, 2025

Vera Therapeutics completes enrollment for IgAN drug trial - Investing.com Australia

Apr 03, 2025

Apr 03, 2025

Vera Therapeutics completes enrollment in ORIGIN Phase 3 trial for atacicept - TipRanks

Apr 03, 2025

Apr 03, 2025

Vera Therapeutics Completes Full Enrollment in Pivotal ORIGIN Phase 3 Trial for Atacicept in IgAN - GlobeNewswire

Apr 03, 2025

Apr 02, 2025

Is Vera Therapeutics Inc (VERA) a threat to investors? - uspostnews.com

Apr 02, 2025

Apr 01, 2025

Teacher Retirement System of Texas Acquires 3,942 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Apr 01, 2025

Mar 31, 2025

Vera Therapeutics (NASDAQ:VERA) Reaches New 1-Year LowWhat's Next? - MarketBeat

Mar 31, 2025

Mar 29, 2025

69,724 Shares in Vera Therapeutics, Inc. (NASDAQ:VERA) Bought by Raymond James Financial Inc. - Defense World

Mar 29, 2025

Mar 26, 2025

Vera Therapeutics stock hits 52-week low at $25.97 By Investing.com - Investing.com South Africa

Mar 26, 2025

Mar 26, 2025

Vera Therapeutics stock hits 52-week low at $25.97 - Investing.com

Mar 26, 2025

Mar 26, 2025

Vera Therapeutics validates Fair Value bearish call with 42% decline By Investing.com - Investing.com UK

Mar 26, 2025

Mar 26, 2025

Swiss National Bank Purchases 15,700 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Mar 26, 2025

Mar 25, 2025

Relative Strength Alert For Vera Therapeutics - Nasdaq

Mar 25, 2025

Mar 22, 2025

AlphaQuest LLC Takes Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Mar 22, 2025

Mar 20, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by Charles Schwab Investment Management Inc. - Defense World

Mar 20, 2025

Mar 17, 2025

Bank of New York Mellon Corp Acquires 7,895 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Mar 17, 2025

Mar 14, 2025

Is Vera Therapeutics (NASDAQ:VERA) Weighed On By Its Debt Load? - simplywall.st

Mar 14, 2025

Mar 14, 2025

Victory Capital Management Inc. Increases Stake in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Mar 14, 2025

Mar 12, 2025

Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of “Buy” by Analysts - Defense World

Mar 12, 2025

Mar 12, 2025

Vera Therapeutics (VERA) Expected to Announce Quarterly Earnings on Wednesday - Defense World

Mar 12, 2025

Mar 11, 2025

Vera Therapeutics Growth Accelerates: 9 Strategic Hires Secure Equity Package Worth $2.3M - StockTitan

Mar 11, 2025

Mar 11, 2025

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - MENAFN.COM

Mar 11, 2025

Mar 08, 2025

What is HC Wainwright’s Estimate for VERA FY2025 Earnings? - Defense World

Mar 08, 2025

Mar 07, 2025

Vera Therapeutics: Does The Earlier Otsuka Launch Harm Its Prospects Much? - Seeking Alpha

Mar 07, 2025

Mar 07, 2025

Cantor Fitzgerald Analysts Lower Earnings Estimates for VERA - Defense World

Mar 07, 2025

Mar 06, 2025

JPMorgan Chase & Co. Has Lowered Expectations for Vera Therapeutics (NASDAQ:VERA) Stock Price - Defense World

Mar 06, 2025

Mar 05, 2025

Vera Therapeutics (NASDAQ:VERA) Price Target Cut to $71.00 by Analysts at JPMorgan Chase & Co. - Armenian Reporter

Mar 05, 2025

Mar 04, 2025

Vera Therapeutics Getting Closer To Key Technical Benchmark - MSN

Mar 04, 2025

Mar 03, 2025

Rhumbline Advisers Has $2.48 Million Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World

Mar 03, 2025

Mar 03, 2025

Q1 EPS Estimates for Vera Therapeutics Boosted by Wedbush - Defense World

Mar 03, 2025

Mar 02, 2025

(VERA) On The My Stocks Page - news.stocktradersdaily.com

Mar 02, 2025

Mar 02, 2025

What is Wedbush’s Forecast for VERA FY2029 Earnings? - Defense World

Mar 02, 2025

Mar 01, 2025

Guggenheim Raises Vera Therapeutics (NASDAQ:VERA) Price Target to $61.00 - Defense World

Mar 01, 2025